2017 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 11 of 44 |
Best rating | 168 % |
Worst rating | -2,028 % |
New companies | |
Negative Economic Capital Ratio | 15 of 44 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 11 of 44 |
Best rating | 168 % |
Worst rating | -2,028 % |
New companies | |
Negative Economic Capital Ratio | 15 of 44 |
Revenues | 24.9 B |
Assets | 34.1 B |
Expenses | 24.5 B |
Stockholders Equity | 12.0 B |
Unprofitable Companies | 26 of 44 |
Source: https://www.germanaccelerator.com Some incredible news at RealRate, folks! We have been [...]
Last week Dr. Holger Bartel, CEO at RealRate, took part in a very [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for U.S. Real Estate [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Semiconductor [...]
Source: https://www.visualcapitalist.com/ranked-the-50-most-valuable-companies-in-the-world-in-2024/ The most avid of RealRate news followers will remember that back [...]
RealRate is proud to announce that our CEO, Holger Bartel, will lecture at [...]
RealRate is honored to be featured once again in the upcoming online seminar [...]
Photo source: https://openai.com/dall-e-3/ RealRate is very excited to announce that the new [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai